IBNI617

Clinical trials for IBNI617 explained in plain language.

Never miss a new study

Get alerted when new IBNI617 trials appear

Sign up with your email to follow new studies for IBNI617, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Gut bacteria may lift depression — a trial puts it to the test

Disease control Not yet recruiting

This trial tests whether a probiotic called IBNI617 can reduce depression symptoms in adults with moderate to severe major depressive disorder. Participants take either the probiotic or a placebo capsule twice daily for 8 weeks. The study measures changes in depression scores and…

Matched conditions: IBNI617

Phase: NA • Sponsor: IBIOME BIOTECHNOLOGY CO., LTD • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

IBNI617

Get alerted when new IBNI617 trials appear

Gut bacteria may lift depression — a trial puts it to the test